Madison Ave. Plays Growing Role in Drug Research
New York Times - 25 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 24 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 23 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 22 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 21 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 21 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Synaptic Agrees to Lundbeck Buyout
ABC News - 21 Nov 2002
... Lundbeck is best known for licensing blockbuster anti-depression drug Celexa
and its successor, Lexapro, to US drugmaker Forest Laboratories Inc. . ...

Synaptic Agrees to Lundbeck Buyout
ABC News - 21 Nov 2002
... Lundbeck is best known for licensing blockbuster anti-depression drug Celexa
and its successor, Lexapro, to US drugmaker Forest Laboratories Inc. . ...

Lundbeck Buys Synaptic for $121 Million
ABC News - 21 Nov 2002
... transaction. Lundbeck is best known for licensing out its anti-depression
drug Lexapro to US drugmaker Forest Laboratories Inc .

Synaptic agrees to Lundbeck buyout for $121 mln
Forbes - 21 Nov 2002
... Lundbeck is best known for licensing out its anti-depression drug Lexapro
to US drugmaker Forest Laboratories Inc (nyse: FRX - news - people).

Johnson & Johnson units to sell Lundbeck's Cipramil , Lexapro in ...
AFX Press - 20 Nov 2002
... an agreement with Janssen-Cilag International, Zug, Switzerland, for the marketing,
sale and distribution of Lundbeck's Cipramil (citalopram) and Lexapro ...

Lundbeck announces strategic alliance to market Cipramil and ...
Pressi.com - 20 Nov 2002
... that it has entered into an agreement with Janssen-Cilag International, Zug, Switzerland,
to promote, sell, and distribute Cipramil (citalopram) and Lexapro ...

The Costly Case of the Purple Pill
Boston Globe, MA - 17 Nov 2002
... Ditto for Forest Laboratories' new antidepressant, Lexapro, the spawn
of Celexa, whose patent is set to expire at the beginning of 2004. ...

Kleptomania study will test drug
Charlotte Observer, NC - 09 Nov 2002
... Aboujaoude's team is working on a placebo-controlled study of whether a drug called
Lexapro, which affects serotonin levels in the brain, works for kleptomania ...

Stocks of the century
CNN - 08 Nov 2002
... share from larger competitors like Merck and Schering-Plough with the help of Celexa
-- and aims to continue the trend with another depression drug, Lexapro. ...

True kleptomaniacs are hard to find
San Francisco Chronicle, CA - 08 Nov 2002
... Aboujaoude's team is working on a placebo-controlled study of whether a drug called
Lexapro, which affects serotonin levels in the brain, works for kleptomania ...

Stanford seeks 24 for study of the rare illness
San Francisco Chronicle, CA - 07 Nov 2002
... Aboujaoude's team is working on a placebo-controlled study of whether a drug called
Lexapro, which affects serotonin levels in the brain, works for kleptomania ...

Stanford seeks 24 for study of the rare illness
San Francisco Chronicle, CA - 07 Nov 2002
... Aboujaoude's team is working on a placebo-controlled study of whether a drug called
Lexapro, which affects serotonin levels in the brain, works for kleptomania ...

Researchers struggling to find kleptomaniacs to come forward
Ananova, UK - 07 Nov 2002
... Dr Aboujaoude's team is working on a study of whether a drug called Lexapro,
which affects serotonin levels in the brain, works for kleptomania. ...

True kleptomaniacs are hard to find
San Francisco Chronicle, CA - 07 Nov 2002
... Aboujaoude's team is working on a placebo-controlled study of whether a drug called
Lexapro, which affects serotonin levels in the brain, works for kleptomania ...

The drug stock cure is debated
Wichita Eagle, KS - 05 Nov 2002
... The New York company's earnings are expected to soar more than 50 percent
this year on strong sales of antidepressant drugs Celexa and Lexapro. ...

The drug stock cure is debated
Miami Herald, FL - 05 Nov 2002
... The New York company's earnings are expected to soar more than 50 percent
this year on strong sales of antidepressant drugs Celexa and Lexapro. ...